Raymond James Financial Services Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-35,079
| Closed | -$6.44M | – | 3373 |
|
2021
Q2 | $6.44M | Buy |
35,079
+3,820
| +12% | +$702K | 0.01% | 860 |
|
2021
Q1 | $4.78M | Sell |
31,259
-8,861
| -22% | -$1.35M | 0.01% | 927 |
|
2020
Q4 | $6.27M | Sell |
40,120
-10,372
| -21% | -$1.62M | 0.02% | 741 |
|
2020
Q3 | $5.78M | Buy |
50,492
+18,439
| +58% | +$2.11M | 0.02% | 698 |
|
2020
Q2 | $3.6M | Sell |
32,053
-2,466
| -7% | -$277K | 0.01% | 840 |
|
2020
Q1 | $3.1M | Buy |
34,519
+10,320
| +43% | +$926K | 0.01% | 697 |
|
2019
Q4 | $2.62M | Buy |
24,199
+1,568
| +7% | +$170K | 0.01% | 1040 |
|
2019
Q3 | $2.22M | Buy |
22,631
+2,297
| +11% | +$225K | 0.01% | 1049 |
|
2019
Q2 | $2.66M | Buy |
20,334
+279
| +1% | +$36.5K | 0.01% | 947 |
|
2019
Q1 | $2.71M | Sell |
20,055
-2,243
| -10% | -$303K | 0.01% | 921 |
|
2018
Q4 | $2.17M | Buy |
22,298
+548
| +3% | +$53.4K | 0.01% | 860 |
|
2018
Q3 | $3.02M | Sell |
21,750
-5,726
| -21% | -$796K | 0.01% | 859 |
|
2018
Q2 | $3.41M | Buy |
27,476
+1,464
| +6% | +$182K | 0.02% | 762 |
|
2018
Q1 | $2.9M | Sell |
26,012
-1,423
| -5% | -$159K | 0.02% | 779 |
|
2017
Q4 | $3.28M | Sell |
27,435
-3,109
| -10% | -$372K | 0.02% | 706 |
|
2017
Q3 | $4.29M | Sell |
30,544
-4,238
| -12% | -$595K | 0.03% | 582 |
|
2017
Q2 | $4.23M | Buy |
34,782
+2,871
| +9% | +$349K | 0.03% | 566 |
|
2017
Q1 | $3.87M | Sell |
31,911
-20,522
| -39% | -$2.49M | 0.03% | 573 |
|
2016
Q4 | $6.42M | Sell |
52,433
-99,772
| -66% | -$12.2M | 0.05% | 374 |
|
2016
Q3 | $18.7M | Sell |
152,205
-478
| -0.3% | -$58.6K | 0.17% | 146 |
|
2016
Q2 | $17.8M | Buy |
152,683
+4,775
| +3% | +$558K | 0.17% | 146 |
|
2016
Q1 | $20.6M | Buy |
147,908
+30,907
| +26% | +$4.3M | 0.24% | 97 |
|
2015
Q4 | $22.3M | Buy |
+117,001
| New | +$22.3M | 0.26% | 90 |
|